Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is GREAT news that Tim has now gone public with HOW he will fund Phase 3 of the FDA clinical trials. This has always been an open issue and concern for me. Congratulations to Tim for keeping the shareholders informed !!!
BusinessWire, GlobeNewswire and PR Newswire News
Therapeutic Solutions International Inc TSOI:OTC Pink - Current Information
Therapeutic Solutions International Secures Financing to Complete Current Phase III Stem Cell Clinical Trial
BusinessWire
9:00 AM ET
Therapeutic Solutions International (TSOI), a clinical stage regenerative medicine and immunotherapy company, announced today it has entered into an agreement with GHS Investments, LLC ("GHS") to purchase up to $10,000,000 of Registered Common Stock.
The agreement is on a look-back basis and there are no make-up provisions, a true non-toxic equity investment. GHS is a leading private investment and management group providing financial solutions for high potential small cap enterprises. GHS has made investments into multiple successful portfolio companies in the nano-market cap space that are seeking capital to measurably grow and scale their existing businesses to take advantage of emerging market sectors.
"This financing will allow the acceleration of our current Phase III clinical trial assessing efficacy of JadiCells, a novel adult stem cell, for treatment of COVID-19 associated lung injury," said Timothy Dixon, President, and CEO of Therapeutic Solutions International. "The implications of this trial are far-reaching in that success will open the door for entry into other pulmonary indications including 'long COVID' which remains a significant health problem."
Therapeutic Solutions International has 66 filed and issued patents, multiple IND's covering Chronic Traumatic Encephalopathy (CTE), Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (C OPD), and solid tumor Cancer's as well as numerous preclinical and pilot clinical data around immunotherapy, oncology, and stem cell therapeutics.
About Therapeutic Solutions International, Inc.
Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com.
View source version on businesswire.com: http s://www.businesswire.com/news/home/20220920005776/en/
SOURCE: Therapeutic Solutions International, Inc."><Property FormalName="PrimaryTwitterHandle" Value="@TSOISupplement
<img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20220920005776r1&sid=cmtx6&distro=nx&lang=en" style="width:0;height:0" />
Timothy G. Dixon ir@tsoimail.com COMTEX_414870123/1006/2022-09-20T09:00:09
threebabie.. I may be mistaken, but from what I understand "At some point" we will need to convert our shares to ADRs IF we want to sell them. Otherwise we won't be able to trade them. This is only true for shares on the OTC (not swiss shares).
To those that are more "in the know" than I, please correct me.
Yes, that is also another high probability outcome. However, it is not the only possible outcome. Time will tell.
Mountain. They may have no intention or desire to be bought out. They may be thinking that there is another way out to get them back on track.
But bottom line is... we are all engaged in pure speculation at this juncture.
All the QNTA investors can do is wait (and hope). "Hope" is not the ideal trading strategy. For those that have a diversified portfolio of investments, this is just small speed bump in the road ahead.
JMHO
If I had to speculate, funding operations is their dilemma. If they can resolve that then they are back in business. At these prices they can't sell shares at this point to raise funds.
They could have executed an R/S long ago to resolve their $ issues. But they didn't. That of course would have wiped out the SH. So that is a good thing for investors.
There is nothing that we can do except wait and see out it unfolds. So in my case, I divert my attention to other stocks in my portfolio.
Ben. sorry. I'm not familiar with that one.
How do you know that it is zero? Please share your DD and facts.
Dr Joey video on Revive
Well, I haven't totally given up yet. But clearly we are skating on some very thin ice. I personally allowed myself to be influenced by a couple of ultra bullish investors on this board wayy back. Investors who posted a ton of DD on this board, but in the end they "got it all wrong". My bad! I should have known better!
Assuming that this boat has zero hope, then I would have to agree.
I'm holding. Never know what will happen. Stranger things have happened in penny world.
Copy That !
Aug 31, 2022 publication. After studying the "Discussion" and "Conclusion" sections, two major points stand out to me:
1) The study was underpowered so the results were heavily skewed against the primary endpoints due to several key sites being overwhelmed (at 200% capacity) with patient beds in parking lots. This threw off the ability to apply aviptadil properly as designed.
2) IMO the study should have had endpoints at 90 days rather than 60 days. 10 of the patients were essentially almost cured by 60 days, but had to be kept in the hospital due to "other" (although related) complications.
I also feel that the definition of the primary endpoint was toooo ambitious. It did not factor in 'improvement' levels.
Primary Endpoint: -- Alive and free from respiratory failure at day 60
All in all, the study was too small, which permitted adverse skewing of results from issues outside the control of the doctors.
It will take a while, but Dr. Leuppi study results (India) should breath a new life into aviptadil !!!
JMHO
https://journals.lww.com/ccmjournal/Fulltext/9900/The_Use_of_IV_Vasoactive_Intestinal_Peptide.40.aspx?fbclid=IwAR1Ek7tEprCDugXiPm-BrF3qwD8PAq5rQbr5eQKXG75fed26QlNeG50t8qo
jackg22... I don't have that much invested in TSOI to spend a lot of time doing DD. But has anyone called the FDA to confirm that Tim is permitted to HIDE from the public ALL official record of him currently engaged in an FDA Phase 3 trial?
I called the FDA once about a year ago with another question (on another ticker) and they were very helpful. My question back then related to EUA during COVID. The FDA told me that (for competitive reasons) a biotech does NOT have to tell the public that they have applied for EUA for a drug.
jackg22, I don't see this as a scam (yet). I see the CEO (Tim) as simply not interested in worrying about the stock price. Rather he wants to pursue the business at hand. My only concern with that approach is.... "Where is he going to obtain the funds to keep running the business down the road?" Dilution at this stock price won't buy him much. Maybe he has a pot of gold somewhere to fund his way through phase 3 FDA trials.
I think we also need a little luck to get out of this mess.
I'll bet the NRX BOD are throwing in the towel considering aviptadil failed the NIH trial. They may figure that it ain't worth the fight anymore. If this is true, that is good for RLFTF because they plan on marketing the drug to ROW using the positive India study as proof that the drug works. We'll see.
Fdc4... well said!
How do you know that? They may have decided that since they need 12+ more months of 'radio silence' to get their ducks in a row, that what's the point of wasting $4,500. We just don't have all of the facts. Everything is speculation.
Yes, the company should issue a PR outlining their future plans. The fact that they are refusing to do that is very disappointing.
fdc4.... exactly!! The SEC is not the FBI. Delisting and fines are the norms when it comes to punishment. This stuff happens all of the time on the OTC and even happens on the NASDAQ. Time will tell how this pans out, but high emotions coupled with wild speculation serves no useful purpose for investors. So I agree with your assessment. Silence is also SOP when any company is under a cloud of investigation.
It's not perfectly clear to me as to where the FRAUD is? Aside from not staying current with the SEC which results in delisting, and not paying all of their bills to CPAs, etc. What other serious fraud do we have evidence of that they committed? Enough to go to jail for? Has the SEC clearly proved that they seriously lied on their financial statements to their investors? Maybe I missed that. Business go bankrupt all of the time due to incompetence. That's not fraud. And promoting a company's business to the public is generally not against the law either.
My thinking is they plan on 'going dark' for a while (maybe a couple of years). Then after they get their ducks in a row they reemerge on the OTC under a new name and ticker. Unfortunately, that strategy could very well spell doom for the current incumbent shareholders. But at this point, selling makes no sense IMO.
Mountain...that begs the question. Is paying the $4,500 a prerequisite (a requirement) to sell the company? I would think not.
Mountain... I tend to agree with you. If they don't rise back up out of the ashes, we may see a name change as part of the sale. The low O/S and float gives them an edge.
jackg22, IMO this is the risk/problem with a scientist also playing CEO and business man. They don't understand business (marketing, finance, IR, strategic planning, and so on).
My concern with this penny stock has always been with the grossly high O/S and float, which makes it ripe for a nasty R/S. However, Tim has gone record in his forum declaring that he'll never do an R/S. We'll see if that holds up when he is desperate for $$ to run the business as he gets deeper into Phase 3 trials. Money doesn't grow on trees.
Why? The PR doesn't generate revenues. The June PDUFA date for ACER-001 was supposed to help with revenues, but they bungled that and now the PDUFA date is pushed off until after the 1st of the new year. So we wait.
I suppose the next big event that hits RLFTF is the ADR conversion of 1 for 150. I have very mixed thoughts about that considering we have no good news catalyst to support the higher PPS. Time will tell.
Keep in mind, QNTA did just conduct a CC with the SH 3 months ago.
Having said that, yes.....they should do another one considering the current state of affairs. They won't be able to talk about the SEC investigation, but they can still update the SH on the business operations and future plans.
Also, I'm very confident that Jedi is just another stuckholder trying to make the best of a very difficult situation.
According to TD Ameritrade, there is still a bid/ask on QNTA. Hence QNTA does not yet qualify as a 'worthless' stock to write off the books.
If you are interested in doing another CC, I would email them and make the request. I believer that the last CC was initiated by a shareholder request. Jedi may be able to shed some light on making such a request. i think Jedi is traveling though.
With regards to this case, I stand corrected. To qualify for 'worthless', there can't be any bid or ask. So QNTA still has a heart beat. No flat-line yet.
Mountain....I am not making a false statement. Please read my post more carefully. As I stated, the broker can "close out" a clients position for a small fee. They can do that without conducting a trade on the open market. I know this to be a fact because I have done this several times over the years. Having said that, I cannot assure anyone that ALL brokers offer this service. But most do.
Dragon wrote....
-------------------------------------------------------------
This SCAM is dead money and now so ill-liquid dead it's going to be tough to even book a tax loss write off on it - unless one just puts their entire holdings up "AT MARKET" and hope they get .0000X per share to execute, which is STILL not likely to happen in the gray sheet land of DEAD TICKER :)
------------------------------------------------------------
This is not correct. Most brokers will easily let you close out a position (without trading it) for a small fee. Usually around $50 or less. Then you can use it as a tax write off.
IMO there will be "NO" news from them on anything until the SEC investigation is behind them. So we simply just wait and hope for the best. Relying on "Hope" is always a bad situation to be in with on any penny stock. But it is what it is. Relax and enjoy "The Sounds of Silence" (the song).
New video out from Dr Joey. Historically Dr Joey has been a major proponent of RLFTF. However, RVVTF has gotten his attention, so we may start seeing several new videos dedicated to RVVTF as a viable investment.
New video out from Dr Joey.
Dr Leuppi is a doctor in Switzerland who is currently conducting an 'inhaler' aviptadil trial with 82 patients with study completion date of Dec 2022. https://clinicaltrials.gov/ct2/show/study/NCT04536350
So he is a STRONG proponent of aviptadil !!
I think the requirement for a miracle is a bit of a stretch. But they do need to survive the SEC investigation. They do that, then we should be off to the races. Unfortunately there is radio silence from both sides during such an investigation. So we patiently wait. It adds no value to let oneself experience grief, anxiety or anger over the situation. It is what it is at this point.
Jedi, I agree. QNTA is 'not' out yet indeed! Only fools with their money panic at this point.
TSOI is a long-term play. The smart investors know that, and they are not consumed or deterred wth/by the daily price fluctuations. Let's see where this is at by YEND 2023.